AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

miRNAs for Prognosis and Prediction of Metastases

Technology Benefits

These biomarkers offer three benefits which are key to clinical and commercial success:1. Multiple applications - Novel, proprietary biomarkers for diagnosis, prognosis and monitoring of CRC 2. Stand-alone or multiplexed - The biomarkers can potentially be used in stand-alone assays, or as part of multiplexed assays to achieve greater sensitivity and specificity3. Integration ΓÇô The biomarkers are compatible with standard molecular platforms and workflows

Technology Application

ΓÇó Cancer screeningΓÇó Differential diagnosis between colorectal cancer with metastasis and without metastasisΓÇó Planning of cancer treatmentΓÇó Evaluation of cancer prognosisΓÇó Monitoring of patients during and after treatmentΓÇó Surveillance in high risk patients (e.g. hereditary predisposition)ΓÇó Cancer research, including clinical developmentΓÇó Development of blood-based assays

Detailed Technology Description

None

Country/Region

USA

For more information, please click Here